Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
60
about 2.7 years
18+
1 site in TN
About this study
This trial is testing how skeletal muscle mitochondria function in people who have survived acute lymphoblastic leukemia (ALL). It involves imaging techniques and blood tests to compare muscle health between ALL survivors and a control group. The goal is to understand the relationship between cancer treatment, muscle weakness, and mitochondrial activity.
Based on ClinicalTrials.gov records.
What participants do
- 1.Magnetic Resonance Spectroscopy
- 2.Peripheral blood sample
- 3.Physical function assessment
- +3 more
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: To explore feasibility of CrCEST MRI to measure OXPHOS capacity, To explore feasibility of Fat Fraction MRI to measure OXPHOS capacity, To explore feasibility of MRI/MRS to measure OXPHOS capacity, To explore feasibility of Muscle Ultrasound to measure OXPHOS capacity
imaging
Oncology